%0 Journal Article
%T Service evaluation project ¨C Are local recommendations for onward referral to a specialist menopause clinic required to translate guidelines into practice?
%A Anne Marie C Neill
%J Post Reproductive Health
%@ 2053-3705
%D 2018
%R 10.1177/2053369118762241
%X Referral audit ¨C are local recommendations required to translate guideline to practice? In total, 50 consecutive, anonymised referral letters reviewed during the initial consultation in a specialist menopause clinic; the reasons for referral along with the patient¡¯s age and the source of referral were analysed. Several common reasons for referral were identified. Sexual dysfunction, including loss of libido and dyspareunia, resulted in 11 (22%) referrals. Ten (20%) women were troubled by persistent symptoms or side effects from HRT; 9 (18%) women were referred before hormone replacement therapy was discussed or commenced; 7 (14%) women seeking advice for their menopausal symptoms had a family or personal history of cancer; 5(10%) were migraineurs; 2(4%) women had premature ovarian insufficiency; 2(4%) were denied hormone replacement therapy because of concern about venous thromboembolism risk; and 4 (8%) had miscellaneous medical disorders. Over 25% of referrals were older than 60. Menopausal symptoms are predominately dealt with in primary care where advice and support is needed. National Institute for Health Care and Excellence published guidance regarding onward referral to a specialist menopause clinic, which is vague and referral patterns are haphazard. Our audit highlighted areas of clinical uncertainty and formed the basis for providing local pre-referral information and advice. Some of the information provided is quite detailed and aimed at healthcare professionals with a special interest in menopause. Further training is now required to improve the quality of referrals. The diversity and complexity of some referrals illustrates the need both for a menopause specialist and clear pathways for further advice or referral within each region
%K Breast cancer
%K estrogen
%K HRT
%K menopause
%K urogenital atrophy
%K vasomotor symptoms
%U https://journals.sagepub.com/doi/full/10.1177/2053369118762241